Acquisition (Details) - Schedule of selling, general and administrative expense - Acquisition [Member] |
12 Months Ended |
---|---|
Dec. 31, 2021
USD ($)
| |
Total consideration paid | |
Cash consideration | $ 350,000 |
Stock consideration | 1,060,150 |
Contingent consideration | 732,287 |
Total | 2,142,437 |
Research and development supplies | (1,548,397) |
Remaining consideration | $ 594,040 |
X | ||||||||||
- Definition Research and development supplies. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of asset recognized arising from contingent consideration in a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Cash received on stock transaction after deduction of issuance costs. No definition available.
|
X | ||||||||||
- Details
|